Physician profile
Jonathan E Weiler
NPI 1396915047
$62,009.10
in general payments reported to CMS, 2019-2025
8 companies · $2,328 in 2025
The $2,328 reported for 2025 was more than what 87% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,803 · 2020: $112 · 2021: $231 · 2022: $22K · 2023: $26K · 2024: $8,667 · 2025: $2,328.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $27K · Consulting Fee: $7,088 · Food and Beverage: $1,918 · Travel and Lodging: $544 · Long Term Medical Supply Or Device Loan: $326.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $26,871.48 |
| Consulting Fee | $7,087.50 |
| Food and Beverage | $1,917.73 |
| Travel and Lodging | $543.57 |
| Long Term Medical Supply Or Device Loan | $326.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $35,059.31 | 2023-2025 | Botox, Natrelle Saline-Filled Breast Implants |
| Allergan, INC. | $25,233.35 | 2019-2022 | |
| Motiva USA, LLC | $919.95 | 2025 | |
| Integra Lifesciences Corporation | $347.18 | 2023 | Durasorb Monofilament Mesh |
| Merz North America, INC. | $344.49 | 2023 | Xeomin |
| Pacira Pharmaceuticals Incorporated | $74.11 | 2021-2025 | Exparel |
| Sientra, INC. | $15.83 | 2022 | |
| Galderma Laboratories, L.P. | $14.88 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Weiler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.